Roche Archives - DelveInsight

Roche

pharma-news-updates-for-roche-mayo-clinic-owlstone-transmedics-google
Roche inks $3B deal; Owlstone raises $58M; FDA approves OCS heart system; Google, Mayo Clinic bui...

Roche’s Genentech taps Adaptimmune for T-Cell Therapy Collaboration for USD 3 BillionA collaboration valued more than USD 3 billion, Genentech, a member of the Roche Group, declared it will co...


top-pharma-biotech-companies-by-revenue-share-drugs-therapies-2020-2021-worldwide
Top 7 Pharma Industry Leaders in 2020 By the Numbers

Pharmaceutical companies play a vital part in our lives and in helping us to live healthier lives. The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutic...


Angelman syndrome
Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current moment because of a shortage of any approved therapy option available in the market.The Angelman Syndrome c...


recent-pharma-happenings-for-asher-bio-roche-novartis-epimab
Asher Bio raises $55M; Roche halts Huntington’s phase 3 trial; Novartis’ radioligand ...

Asher Bio raises USD 55 Million in Series A financingAsher Biotherapeutics, a biotechnology company developing exactly targeted immunotherapies for cancer and other diseases, raised USD 55 Mil...


Head and Neck Cancers Market
Navigating Through the Treatment Market Landscape of Head and Neck Cancers

Head and neck cancer account for about 4% of all cancers in the United States. According to GloboCan, the HNSCC incidence in the US in 2020 was estimated to be 63,520 cases. As per estimates, it w...


Angelman Syndrome Market Landscape and Late-stage Clinical Failures
Angelman Syndrome Market: Insights Into The Recent Late-Stage Drug Failures And Novel Approaches ...

Angelman syndrome (AS) is a complex genetic rare disorder that affects the nervous system. The first sign of a child suffering from Angelman syndrome is a delay in development, such as the inabili...


recent-pharma-biotech-healthcare-news-and-updates-for-nih-roche-regeneron-gsk
NIH awards $107M for COVID-19 testing tech; GSK secures rights; Roche’s bispecific matches ...

NIH awards USD 107 Million for radical COVID-19 testing tech The National Institutes of Health (NIH) awarded over USD 107 million for radical approaches to testing for COVID-19 and tracin...


recent-pharma-biotech-news-and-updates-for-zimmer-bayer-ovid-merck-janssen-roche
Roche’s quantitative COVID-19 antibody test; Janssen buys a gene therapy asset; Zimmer Acqu...

Roche receives FDA authorization for the quantitative COVID-19 antibody testRoche has got an authorization from the FDA for a more accurate COVID-19 blood test capable of measuring the levels ...


pharma-news-for-roche-prestige-covid-19
Venclexta full approval; PBP1510 Orphan Status; Roche/ Genesis collab; Immunomodulators for COVID-19

Full FDA Approval for Venclexta Combinations for Acute Myeloid LeukemiaThe US FDA has granted its full approval to Venclexta (venetoclax) for newly diagnosed acute myeloid leukemia (AML) in ...


recent-pharma-news-updates-cyclerion-nimbus-dyno-rayzebio
Cyclerion’s olinciguat flunks sickle cell test; Nimbus nets $60M; Dyno-Roche’s gene t...

Cyclerion flunks sickle cell test, prompting pivot to CNS diseaseCyclerion Therapeutics has terminated the development of olinciguat in sickle cell disease after getting a look at data from a ...


Editor's Pick
Healthcare Data Breach: What it Means for Companies and the Consumer?

Data and analytics today are playing a major role in the organization’s growth. Stakeho...

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Co...

Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...

Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...

The New Buzz of Transcranial Stimulation Devices in the Neurological Disorder...

Neurological disorders are one of the major causes of death and disability across the g...

Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Maj...

As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.